Skip to main content

NIA Funding Policy for FY 2015

NIA Final Funding Lines for RPG Awards FY 2015

General Pay Line (other than Alzheimer’s research)

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

8%*

5%

N.I. R01s

16%

13%

E.S.I. R01s

18%

15%

N.I. is New Investigator (no prior R01 or R01-equivalent award from NIH)

E.S.I. is Early-Stage Investigator (no prior R01 or R01-equivalent award and within 10 years of finishing research training).

*NIA made a number of awards to applications scoring at the 9thpercentile and above. Many of these were one year (R56) short-term, high priority awards and others were awards supported through a small discretionary pool of funds assigned to the individual research program divisions.

Alzheimer’s Research Pay Line

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

18%

15%

N.I. R01s

21%

18%

E.S.I. R01s

23%

20%

An application is considered to be on the topic of Alzheimer’s if the Research, Condition, and Disease Categorization (RCDC) process assigns the Alzheimer’s category to the application.

July 2015 Update: Adjustments to Several Funding Lines

Research Grants:

The general pay line remains unchanged as shown in the April 2015 update below. The new pay lines for research focused on Alzheimer’s disease are:

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

17%

14%

N.I. R01s

21%

18%

E.S.I. R01s

23%

20%

N.I. is New Investigator (no prior R01 or R01-equivalent award from NIH)

E.S.I. is Early-Stage Investigator (no prior R01 or R01-equivalent award and within 10 years of finishing research training)

Career Awards

NIA is extending the NIA career award pay line for 2015 to 19. Additionally we are paying career awards targeting Alzheimer’s disease to a score of 27.

Small Business Research

NIA is holding the May round of Small Business Innovative Research (SBIR) awards to a score of 28. This tighter line results in part from a need to hold funds to pay at least some applications from the April 2015 submission date round before the end of 2015. Additionally NIA is paying SBIR applications targeting Alzheimer’s disease to a score of 40. NIA is also paying Small Business Technology Transfer Research (STTR) awards to a score of 40. That is a general pay line for these STTR awards.

May 2015 Update: Funding line Update for Research on Alzheimer's Disease

CSR-Reviewed Applications

NIA is extending the pay line for CSR-reviewed research grant applications that focus on Alzheimer’s disease as shown in the table below. We may extend this pay line further towards the end of FY 2015.

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

14%

11%

N.I. R01s

18%

15%

E.S.I. R01s

20%

17%

N.I. is New Investigator (no prior R01 or R01-equivalent award from NIH)

E.S.I. is Early Stage Investigator (no prior R01 or R01-equivalent award and within 10 years of finishing research training).

NIA-Reviewed applications

NIA is continuing to pay NIA-reviewed research grant applications that focus on Alzheimer’s disease to a score of 15.

Administrative Cuts

NIA will continue to a policy of holding to an average 18% cut on all competing research grant awards, other than small grants (R03) and exploratory/developmental awards (R21). These latter awards will generally receive the study-section recommended amounts of support. The 18% cut is an average. Individual awards may be reduced more or less than that amount.

Other Grant Mechanisms

NIA anticipates establishing final 2015 pay lines for Alzheimer’s-focused applications in Small Business awards and career awards by the end of June.

April 2015 Update

At this time most competing applications for fiscal year 2015 have been reviewed and NIA is in a better position to establish a research grant pay line for the year. Though a few uncertainties do remain we do not expect their outcome to change the pay line further. The table below shows the 2015 pay line for CSR-reviewed, research grant applications.

CSR-reviewed Applications

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

8%

5%

N.I. R01s

12%

9%

E.S.I. R01s

14%

11%

N.I. is New Investigator (no prior R01 or R01-equivalent award from NIH).

E.S.I. is Early-Stage Investigator (no prior R01 or R01-equivalent award and within 10 years of finishing research training).

NIA-reviewed Applications

NIA expects to pay all research applications (program projects, cooperative agreements, and R01s reviewed by NIA) scoring between 10 and 12. We will reduce the size of some of the awards we make significantly in order to do that.

Career Awards and Fellowships

NIA intends to pay career award applications through a score of 18 and most fellowship applications through a score of 30. Some adjustment to these lines is possible later in the year.

Small Business Awards

NIA will post information on the small business funding lines (SBIR and STTR) within the next few weeks.

FY 2015 Funding Line Policy: Additional Appropriation

In February we published information on our interim funding line for applications that focus on Alzheimer's disease. We will provide updated information on allocations using that appropriation in the near future.

February 2015 Update: Alzheimer's Disease Funding

CSR-reviewed applications:

NIA is extending the pay line for CSR-reviewed research grant applications that focus on Alzheimer’s disease as shown in the table below:

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

11%

8%

N.I. R01s

14%

11%

E.S.I. R01s

16%

13%

N.I. is New Investigator (no prior R01 or R01-equivalent award from NIH)

E.S.I. is Early Stage Investigator (no prior R01 or R01-equivalent award and within 10 years of finishing research training)

NIA-reviewed applications

NIA is paying NIA-reviewed research grant applications that focus on Alzheimer’s disease to a score of 15.

Administrative cuts

NIA will continue a policy of holding to an average reduction of 18% on all competing research grant awards, other than small grants (R03s) and exploratory/developmental awards (R21). These latter awards will generally receive the study-section recommended amount of support. The 18% cut is an average. Individual awards may be reduced by more or less than that amount.

Career Development Applications

NIA is paying career development applications that focus on Alzheimer’s disease to a score of 20.

Small Business Innovative Research Applications (SBIR)

NIA is paying SBIR applications that focus on Alzheimer’s disease to a score of 42.

Future update

NIA anticipates a further update on funding for Alzheimer’s disease research later in the year. Change is possible in all the lines shown above.

January 2015 Update

NIA received a full year appropriation on December 16, 2014. The FY2015 level is $1,199,468,000, which represents a 2.4% increase over FY 2014 with most of the increase ($25 million) targeted towards Alzheimer’s funding. NIA has received substantially more R01 applications for funding consideration in 2015 relative to immediate prior years, particularly following the change in policy announced in April 2014 that allows subsequent applications to be submitted on a topic similar to previously unfunded submissions. At this time NIA is taking action anticipating (and reacting) to the additional volume of applications that we expect to obtain or have obtained outstanding reviews.

NIH published the NIH Fiscal Policy for Grant Awards – FY 2015 on December 30, 2014. NIA is following the guideline in that statement for non-competing continuation grants (Type 5) and making awards at 3% below the committed level for FY2015. Out-year commitments beyond FY 2015 remain unchanged. With that change NIA has established the following funding lines for FY 2015 for competing awards:

CSR-reviewed applications

Requested Direct Costs <500k 500k or greater

All applications except N.I. or E.S.I. R01s

7%

4%

N.I. R01s

10%

7%

E.S.I. R01s

12%

9%

N.I. is New Investigator (no prior R01 or R01-equivalent award from NIH)

E.S.I. is Early-Stage Investigator (no prior R01 or R01-equivalent award and within 10 years of finishing research training.)

NIA-reviewed applications

NIA is not establishing a payline for NIA-reviewed applications. Instead a senior executive committee will consider applications for funding within the band of scores from 10 to 12 using the criteria in our Strategic Directions document.

Administrative Cuts

NIA will continue a policy of holding to an average reduction of 18% on all competing research grant awards other than small grants (R03s) and exploratory/developmental awards (R21). These latter awards will generally receive the study-section recommended amount of support. The 18% cut is an average. Individual awards may be reduced by more or less than that amount.

Career Awards, Small Business Awards, Fellowships

Because NIA receives a smaller volume of applications in these lines than in research grant lines it is impossible to estimate a payline accurately until after the May Council round of applications have been reviewed. NIA will continue paying career awards to a score of 14 and Small Business Innovation Research awards to a score of 35. We anticipate extending these lines following review of the May Council round applications.

FY 2015 Policy: Additional Appropriation

As described above, most of the 2.4% increase for NIA in FY 2015 is directed towards Alzheimer's research. In particular, $25 million is provided as an increase beyond prior levels of support.

As in FY 2014, NIA plans to use these additional FY 2015 funds to support Alzheimer's research in areas of strategic priority. These include applications received in response to recent funding announcements that target Alzheimer's Disease and extending the funding line for applications focused on Alzheimer's Disease.

NIA will distribute these new funds among single-year awards (incrementally funded) and multi-year awards (funds for all years awarded in a single year). The overall aim is to maintain a stream of new competing dollars to support high quality peer-reviewed research on aging and Alzheimer's Disease in later years, where additional appropriations are uncertain.

Future Update

NIA anticipates making a further update to our funding policy later in the year. Changes are likely in career award and small business pay lines. Change is possible in the pay lines for CSR-reviewed applications depending on the outcome of reviews and other variables that remain unresolved at this time.

December 2014 Update

NIH (including NIA) is currently supported under a continuing resolution that expires on December 11. Some uncertainty remains about both our final budget for FY2015 and the number and cost of applications obtaining competitive scores in FY2015 – following the change in policy announced in April 2014 that allows subsequent applications to be submitted on a topic similar to previously unfunded submissions.

For these reasons at this time NIA is making awards to the 5th percentile only for CSR-reviewed applications from the October 2014 Council. NIA is paying NIA-Reviewed program project applications and multi-site applications with scores of 10 or 11 only. Career award applications from the October 2014 round are being paid to a score of 14. Small Business applications are being paid to a score of 35.

Although NIA expects to establish separate pay lines for new and early-stage investigator R01 applications and to differentiate in the funding line between applications requesting under $500k a year and those requesting 500k and over a year, no decisions on these separate pay lines will be made until we have a final budget for the year.

In this interim period we will continue to reduce research grant awards, other than small grants (R03) and exploratory/developmental (R21) awards, by an average of 18% below requested costs. We will award R03 and R21 awards at the study section recommended amount.

We will make non-competing research grant (Type 5) awards at 90% of their committed level for FY2015 and adjust them when we know our budget for the year.

We will update this page when we know our final budget.